Top section
Top section
Sale comes after the expiry last month of a pre-emptive acquisition rights agreement between the main family holding companies
Placing and open offer follows recent acquisition of US annuity provider
Long-time owners sell 0.5% stake after strong results
More articles
More articles
More articles
-
Mahindra and Mahindra Financial Services has raised Rp30.9bn ($412.4m) after wrapping up an oversubscribed rights issue. -
Ant Group has picked two large Chinese securities houses as advisors for the China leg of its dual listing in Hong Kong and Shanghai. The duo are also likely to be the sponsors for the much-anticipated deal.
-
Nongfu Spring, a Chinese bottled water and beverage company, has kicked off pre-deal investor education for its Hong Kong IPO.
-
Chinese biotechnology company JW (Cayman) Therapeutics is planning to float on Hong Kong’s stock exchange. It has filed a draft prospectus with the bourse.
-
This week in Keeping Tabs: whether investors are prepared for the impact of a Joe Biden win on environmental policy, how bond and syndicated loan markets diverged in the crisis, and a crypto app that tanked.
-
Germany’s CureVac has gone public on the Nasdaq, joining the army of biotech companies that have tapped the equity capital markets for cash during the pandemic, despite growing concern of a brewing dot-com style bubble.
Sub-sections
shared comment list
